JNJ-64619178
JNJ-64619178 is a potent, orally bioavailable, and pseudo-irreversible PRMT5 inhibitor with an IC50 of 0.14 nM. It demonstrates promising anti-tumor efficacy in both in vitro and in vivo models of lung cancer, making it a valuable tool for oncology research.
Product Specifications
CAS Number
2086772-26-9
Product Name Alternative
HistoneMethyltransferase, Histone Methyltransferase, Inhibitor, JNJ64619178, JNJ-64619178, JNJ 64619178, inhibit, Onametostat, PRMT5
Field of Research
Epigenetics & Chromatin
Purity
98.44% (May vary between batches)
Solubility
DMSO:120 mg/mL (248.26 mM) ;10% DMSO+40% PEG300+5% Tween-80+45% Saline:3.3 mg/mL (6.83 mM)
Smiles
Nc1nc2cc (CC[C@H]3C[C@H] ([C@H] (O) [C@@H]3O) n3ccc4c (N) ncnc34) ccc2cc1Br
Molecular Formula
C22H23BrN6O2
Molecular Weight
483.36
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV647257 1.0 µg DNA
MTTP Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details